RESECTABLE PANCREATIC CANCER
Clinical trials for RESECTABLE PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against tough pancreatic tumors
Disease control CompletedThis study tested a combination of four drugs (paclitaxel protein bound, gemcitabine, cisplatin, and paricalcitol) given before surgery to people with pancreatic cancer that could be removed or was borderline removable. The goal was to see if this treatment could shrink tumors en…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Scientists track tumor DNA during pancreatic surgery
Knowledge-focused CompletedThis study looked at 35 people having surgery for pancreatic cancer. Researchers measured tumor DNA in the blood before, during, and after surgery to see how the operation affects DNA levels. The goal was to learn if these DNA changes relate to survival and cancer return.
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC